title: Opportunistic parasitic infections of the intestinal tract in the era of highly active antiretroviral therapy: is the CD4(+) count so important?
authors.forename: P
authors.initials: P
authors.lastname: Maggi
authors.forename: A M
authors.initials: AM
authors.lastname: Larocca
authors.forename: N
authors.initials: N
authors.lastname: Ladisa
authors.forename: S
authors.initials: S
authors.lastname: Carbonara
authors.forename: O
authors.initials: O
authors.lastname: Brandonisio
authors.forename: G
authors.initials: G
authors.lastname: Angarano
authors.forename: G
authors.initials: G
authors.lastname: Pastore
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000276:immunology*; D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D003457:Cryptosporidiosis / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy / Q000276:immunology*; D021865:Isosporiasis / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D008875:Middle Aged
chemical_list: D000981:Antiprotozoal Agents